
US Patent Application No: 2011/0243,899
Number of patents in Portfolio can not be more than 2000
Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein
Stats
-
Oct 6, 2011
Publication date -
Apr 23, 2009
filing date -
12/988,533
serial no -
Published
status
Importance
Abstract
Provided is a novel soluble factor that modulates morphogenesis and cell proliferation, such as cardiac development and/or cardiomyocyte differentiation. Specifically provided are: an inhibitor of Wnt signalling, comprising an insulin-like growth-factor-binding protein (IGFBP), the protein being binding to a Wnt receptor, and/or a polynucleotide encoding the protein; a medicament for prevention and/or treatment of a disease due to enhanced Wnt signalling, comprising the inhibitor of Wnt signalling, and a medicament for induction of cardiomyocyte differentiation; and a method for prevention and/or treatment of a disease due to enhanced Wnt signalling and a method of inducing cardiomyocyte differentiation, the methods each comprising using the inhibitor of Wnt signalling, and a cardiomyocyte, which is obtained by the method of inducing cardiomyocyte differentiation, and a use thereof.
First Claim
Related Publications